Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 9, 2021
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
[ Mon, Aug 09th 2021
] - WOPRAI
Kennen MacKay Initiated (ADCT) at Buy and Held Target at $33 on, Aug 9th, 2021
Kennen MacKay of RBC Capital, Initiated "ADC Therapeutics SA" (ADCT) at Buy and Held Target at $33 on, Aug 9th, 2021.
Kennen has made no other calls on ADCT in the last 4 months.
There are 3 other peers that have a rating on ADCT. Out of the 3 peers that are also analyzing ADCT, 0 agree with Kennen's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Kennen
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $51 on, Friday, July 16th, 2021
- Brian Cheng of "Cantor Fitzgerald" Initiated at Buy and Held Target at $46 on, Tuesday, June 15th, 2021
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $55 on, Friday, May 14th, 2021
